Treatment with Imcivree (setmelanotide), Rhythm Pharmaceuticals’ approved injection therapy for acquired hypothalamic obesity (aHO), helped children and adults…
Margarida Maia
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia
People with Bardet-Biedl syndrome (BBS) show a wide range of cognitive skills, but verbal skills do not seem to…
The European Commission (EC) has approved Imcivree (setmelanotide) to treat obesity and control hunger in people ages 4 years…